Iii международная научно-практическая конференция

List of reference:
1.
Global Hepatitis Report 2017, WHO
2.
Ruksana Raihan Hepatitis in Malaysia: Past, Present, and Future. 
Euroasian Journal of Hepato-Gastroenterology. 2016, 6(1):52-55 
3.
Muhamad NA et.al. 2020
,
Seroprevalence of hepatitis B virus and 
hepatitis C virus infection among Malaysian population. Nature Sci Report, 10:21009 
DOI: 10.1038/s41598-020-77813-5 

---

III Международная научно-практическая конференция
 
190 
III International Scientific and Practical Conference 
4.
Hong Tang Editor. Hepatitis B virus Infection, Molecular Virology to 
Antiviral Drugs, Springer Nature Singapore 2020 
5.
Nese Demirturk & Tuna Demirdal 2014, Inactıve hepatitis B surface 
antigen carriers and intrafamilial tramsmission: results of a 10-year study. Clinical 
and Molecular Hepatology;20:56-60 
6.
Chapter 15, Liver, Gallbladder and Biliary tract, in Robbins basic 
pathology, Ed Kumar, Abbas, Aster. 9th ed. Int Edition Elsevier Saunders 
Philadelphia, PA 2013 
7.
Chu C, Karayiannis P, Fowler M et al. Natural History of Chronic 
Hepatitis B virus infection in Taiwan; Studies of Hepatitis B Virus DNA in serum. 
Hepatology 1985; 5: 431-434 
8.
Sharma et.al Hepatitis B virus: Inactive Carriers Virol J. 28;2:82. 2005
doi: 10.1186/1743-422X-2-82. 
9.
Lingzhi-Ganoderma 
in 
Chinese 
Pharmacopeia 
2000. 
P.146. 
Pharmacopoeia Committee of P. R. China in Pharmacopoeia of People’s Republic of 
China (Volume I). Chemical Industry Publishers, Beijing,
10.
Qiu, Zhong & Yang, Chapter 9, Protective and Therapeutic Effect of 
Ganoderma (Lingzhi) on liver injury, in Ganoderma and Health: Pharmacology and 
Clinical Application, Zhibin Lin & Baoxue Yang Editors. Springer Natural Singapore 
2019 
11.
Paterson R.R.M. Ganoderma- A therapeutic fungal biofactory. In 
Phytochemistry 2006, VOL. 67. P.1985-2001 
12.
Roy Upton, Reishi Mushroom, Ganoderma lucidum: Standard of 
analysis, Qualify Control, and Therapeutics, American Herbal Pharmacopoeia and 
Therapeutic Compendium 2006. 
13.
Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF., Chapter 9: 
Ganoderma lucidum (lingzhi or Reishi): In A Medicinal Mushroom, in Benzie IFF, 
Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd 
edition. 2011 P. 175-199. Boca Raton (FL): CRC Press/Taylor & Francis 
14.
Bishop K.S., Kao C.H.J., Xu, Y., Glucina M.P, Paterson R.R.M, 
Ferguson L.R. From 2000 years of Ganoderma lucidum to recent development in 
nutraceuticals. Phytochemistry; 2015, VOL 114. P. 56-65 
15.
Hu, Ganoderma capsule in treatment of chronic HBV analysis of 86 
case Occupation and Health,2003,19(3): 103-104 (article in Chinese) 
16.
Chen et.al. Combining Lamivudine with Ganoderma capsule for the 
treatment of Chronic HBV: 30 cases clinical observation J New Chinese Medicine, 
2007. 39(3): 78-79 (article in Chinese) 
17.
LI & Wang, Anti-hepatitis B activities of ganoderic acid from 
Ganoderma lucidum Biotechnol Lett; 2006, 28:837–841 
18.
Chie et.al. Triterpenoids and polysaccharide peptides enriched 
Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study 
of its antioxidation and hepatoprotective efficacy in healthy volunteers. 
Pharmaceutical Biology, 55:1, 1041-1046, DOI: 10.1080/13880209.2017.1288750 

---